Does Aetna (CVS Health) Cover Enclomiphene Citrate?
Aetna (CVS Health) may cover enclomiphene citrate for secondary hypogonadism with prior authorization and step therapy. Learn PA criteria, appeal steps, formulary tier, and cost details.
Enclomiphene
87 source-based articles maintained by the HealthRX.com Editorial Team.
87articles
7topic areas covered
May 26, 2026latest review
Enclomiphene library
Showing 87 of 87 clinical reviews.
Does Anthem (Elevance Health) Cover Enclomiphene Citrate?
A clinical guide to Anthem (Elevance Health) coverage, prior authorization criteria, step therapy requirements, and appeal strategies for enclomiphene citrate prescriptions.
Does Blue Cross Blue Shield (Federated) Cover Enclomiphene Citrate?
Find out whether Blue Cross Blue Shield Federated plans cover enclomiphene citrate for secondary hypogonadism, including prior authorization criteria, formulary status, step therapy rules, and how to appeal a denial.
Does Cigna Cover Enclomiphene Citrate?
A clinical and insurance guide to Cigna coverage, prior authorization, step therapy, and appeal strategies for enclomiphene citrate prescriptions. prepared by the HealthRX.com Editorial Team.
Does Humana Cover Enclomiphene Citrate? Prior Authorization, Formulary Tier, and Appeal Steps
Find out whether Humana commercial and Medicare Advantage plans cover enclomiphene citrate for hypogonadism, including prior authorization criteria, step therapy requirements, formulary status, and how to appeal a denial.
Does Medicare Advantage Cover Enclomiphene Citrate?
Medicare Advantage plans rarely cover enclomiphene citrate because it lacks standalone FDA approval. Learn about formulary status, prior authorization, appeals, and affordable alternatives.
Does State Medicaid Cover Enclomiphene Citrate?
A state-by-state guide to Medicaid coverage, prior authorization, step therapy, and appeal strategies for enclomiphene citrate prescribed for secondary hypogonadism.
Does TRICARE Cover Enclomiphene Citrate?
How to check a current TRICARE benefit for enclomiphene citrate without relying on generic approval, pricing, or prior-authorization claims.
Enclomiphene Citrate Adolescent (12 to 17) Dosing: What Clinicians Need to Know
A comprehensive clinical guide to enclomiphene citrate dosing in adolescents aged 12, 17 with secondary hypogonadism, covering off-label rationale, dose ranges, monitoring protocols, and safety considerations prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Adult (30 to 49) Monitoring: Complete Clinical Guide
A guide to monitoring enclomiphene citrate therapy in men aged 30, 49, covering lab schedules, dose adjustments, safety endpoints, and when to stop treatment.
Enclomiphene Citrate Adult (30-49) Dosing: Complete Clinical Guide
Evidence-based dosing guide for enclomiphene citrate in men aged 30-49 with secondary hypogonadism. Covers starting doses, titration, monitoring, and clinical trial data prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Cost in Arizona 2026
How much does enclomiphene citrate cost in Arizona in 2026? Cash prices, compounded options, insurance coverage, Arizona Medicaid status, and telehealth access explained with cited clinical data.
Enclomiphene Citrate Cost in Arkansas 2026
A complete guide to enclomiphene citrate pricing, insurance coverage, Medicaid status, compounding legality, and discount options for Arkansas residents in 2026.
Enclomiphene Citrate Cost in California 2026
A breakdown of enclomiphene citrate prices in California for 2026, covering cash-pay rates, compounded options, Medi-Cal coverage, insurance prior authorization, telehealth access, and discount strategies.
Enclomiphene Citrate Cost in Florida 2026
A complete breakdown of enclomiphene citrate pricing in Florida for 2026, including cash-pay rates, compounded options, insurance coverage, Medicaid status, and telehealth access.
Enclomiphene Citrate Cost in Maryland 2026: Cash Price, Insurance, Medicaid, and Compounding
A Maryland-specific breakdown of enclomiphene citrate prices in 2026, covering cash-pay rates, Medicaid prior authorization, 503A compounding legality, telehealth access, and every discount path available to Maryland residents.
Enclomiphene Citrate Cost in Massachusetts 2026
Exact 2026 prices for enclomiphene citrate in Massachusetts: cash-pay retail, compounded 503A, telehealth options, MassHealth Medicaid coverage rules, insurance PA requirements, and discount strategies explained with clinical citations.
Enclomiphene Citrate Cost in New York 2026
Complete 2026 guide to enclomiphene citrate pricing in New York: cash-pay costs, compounded options, Medicaid coverage, insurance rules, and telehealth access. Reviewed by HealthRX.com physicians.
Enclomiphene Citrate Cost in North Carolina 2026
Real 2026 pricing for enclomiphene citrate in North Carolina: cash-pay rates, compounded 503A options around $90/month, Medicaid coverage gaps, insurance tips, and telehealth access explained by the HealthRX.com medical team.
Enclomiphene Citrate Cost in Oregon 2026
Exact 2026 pricing for enclomiphene citrate in Oregon: cash-pay retail, compounded 503A, telehealth options, Oregon Medicaid coverage with prior authorization, and insurance tips, prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Cost in Pennsylvania 2026
Complete 2026 price guide for enclomiphene citrate in Pennsylvania: cash-pay rates, compounded 503A options, Medicaid coverage, telehealth access, and real strategies to reduce your out-of-pocket cost.
Enclomiphene Citrate Cost in Tennessee 2026
Exact 2026 prices for enclomiphene citrate in Tennessee, including compounded 503A options around $90/month, telehealth access, Medicaid coverage status, and insurance tips for TN residents.
Enclomiphene Citrate Cost in Utah 2026
What enclomiphene citrate actually costs in Utah, why there is no FDA-approved commercial version, how Medicaid and private insurance treat it, and what to verify before paying a compounding pharmacy in 2026.
Enclomiphene Citrate Cost in Virginia 2026
A complete 2026 guide to enclomiphene citrate pricing in Virginia, covering cash-pay rates, compounded options through 503A pharmacies, Virginia Medicaid coverage with prior authorization, insurance pathways, and telehealth access for men with secondary hypogonadism.
Enclomiphene Citrate Cost in Washington 2026: Cash Pay, Insurance, and Compounded Options
Up-to-date breakdown of enclomiphene citrate prices in Washington state for 2026, including cash-pay retail rates, compounded 503A pharmacy costs, Medicaid coverage rules, telehealth access, and discount strategies.
Enclomiphene Citrate Cost in Wyoming 2026: Cash Pay, Compounded, and Insurance Guide
A complete 2026 breakdown of enclomiphene citrate pricing in Wyoming, covering cash-pay retail, 503A compounded options (~$90/month), Wyoming Medicaid status, telehealth access, and how to minimize out-of-pocket costs.
Enclomiphene Citrate Cost vs. Alternatives in Class
A clinical comparison of enclomiphene citrate pricing, efficacy, and side-effect profile against clomiphene, tamoxifen, anastrozole, hCG, and exogenous testosterone for secondary hypogonadism.
Enclomiphene Citrate Dosing for Older Adults (Ages 50 to 64)
A guide to enclomiphene citrate dosing in the 50, 64 age group, covering starting doses, titration, monitoring labs, cardiovascular considerations, and how older-adult physiology changes the risk-benefit calculation.
Enclomiphene Citrate Dosing for Young Adults (18 to 29): Evidence, Protocols, and Monitoring
Clinical dosing guide for enclomiphene citrate in young adults aged 18 to 29 with secondary hypogonadism, covering starting doses, titration, lab monitoring, and fertility preservation.
Enclomiphene Citrate Dosing in Hepatic Impairment
Evidence-based guidance on enclomiphene citrate dose adjustments for patients with liver disease, including Child-Pugh-based recommendations, monitoring protocols, and alternative strategies.
Enclomiphene Citrate Dosing in Renal Impairment
Evidence-based guidance on enclomiphene citrate dosing for patients with renal impairment, including pharmacokinetic considerations, CKD-related hypogonadism, and monitoring recommendations.
Enclomiphene Citrate Drug-Drug Interactions: A Complete Clinical Profile
Full drug-drug interaction profile for enclomiphene citrate, including CYP enzyme effects, hormonal co-therapies, and safety data from clinical studies.
Enclomiphene Citrate Food & Supplement Interactions
A clinical guide to food and supplement interactions with enclomiphene citrate, including CYP enzyme effects, phytoestrogens, fat-soluble nutrient timing, and supplements that may alter efficacy.
Enclomiphene Citrate for Secondary Hypogonadism: Evidence, Dosing, and What to Expect
A comprehensive clinical review of enclomiphene citrate for secondary hypogonadism: how it works, what the trial data show, dosing protocols, side effects, and who qualifies for treatment.
Enclomiphene Citrate Geriatric (65+) Dosing: What Older Men Need to Know
A guide to enclomiphene citrate dosing in men aged 65 and older, covering starting doses, titration, renal and hepatic adjustments, fall risk, drug interactions, and monitoring protocols for secondary hypogonadism.
Enclomiphene Citrate Geriatric (65+) Monitoring: Lab Schedule, Safety Checks, and Dose Adjustments
Evidence-based monitoring protocol for enclomiphene citrate in adults 65 and older, covering lab timing, cardiovascular screening, drug interactions, and deprescribing criteria.
Enclomiphene Citrate in Adults 65 and Older: What the Evidence Says About Safety
A clinical review of enclomiphene citrate safety in geriatric patients (65+), covering cardiovascular risk, drug interactions, renal considerations, and monitoring protocols for older men with secondary hypogonadism.
Enclomiphene Citrate in Special Populations: Transplant, HIV, Chronic Disease, and Beyond
Evidence-based guide to enclomiphene citrate use in special populations including organ transplant recipients, people living with HIV, chronic kidney disease, liver disease, and older adults.
Enclomiphene Citrate Manufacturing, Supply & Shortage History
A clinical deep-dive into enclomiphene citrate's manufacturing origins, FDA regulatory status, compounding pharmacy supply chains, and the shortage events that have shaped patient access since 2012.
Enclomiphene Citrate Mechanism of Action: The Full Hormonal Pathway Explained
A physician-level explanation of how enclomiphene citrate restores testosterone through hypothalamic estrogen receptor antagonism, GnRH upregulation, and downstream gonadotropin signaling while preserving spermatogenesis.
Enclomiphene Citrate Missed-Dose Protocol
What to do if you miss a dose of enclomiphene citrate, how its pharmacokinetics inform safe catch-up timing, and when to simply skip and resume your regular schedule.
Enclomiphene Citrate Monitoring for Older Adults (Ages 50 to 64): A Complete Clinical Guide
A guide to monitoring enclomiphene citrate in adults aged 50, 64, covering lab schedules, cardiovascular risk, polypharmacy, and dose adjustments for secondary hypogonadism.
Enclomiphene Citrate Monitoring for Young Adults (Ages 18 to 29)
A complete clinical guide to monitoring enclomiphene citrate in men aged 18, 29 with secondary hypogonadism, covering lab schedules, fertility preservation, dose adjustments, and safety checkpoints prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Monitoring in Adolescents (Ages 12 to 17): A Clinical Guide
A detailed clinical guide to monitoring enclomiphene citrate therapy in adolescent males aged 12-17 with secondary hypogonadism, covering lab schedules, growth surveillance, mental health tracking, and safety thresholds.
Enclomiphene Citrate Monitoring Schedule: Labs and Exams You Need
Evidence-based monitoring schedule for enclomiphene citrate therapy, including baseline labs, follow-up blood work timelines, and clinical exams required during treatment for secondary hypogonadism.
Enclomiphene Citrate Off-Label Uses: Evidence Levels, Mechanisms, and Clinical Applications
A guide to enclomiphene citrate off-label uses, covering secondary hypogonadism, male infertility, PCOS, and more, with evidence grades, named trials, doses, and primary-source citations.
Enclomiphene Citrate Overdose and Accidental Excess Dose: Recognition, Risks, and Clinical Management
A cautious, evidence-boundary guide to enclomiphene citrate overdose recognition and accidental excess dose management, prepared for editorial and qualified medical review.
Enclomiphene Citrate Patent Field and Generic Timeline
A deep dive into enclomiphene citrate's mechanism, patent history, FDA regulatory status, and when a generic version is realistically expected.
Enclomiphene Citrate Pediatric (Under 12) Dosing: What Clinicians and Parents Need to Know
A comprehensive clinical review of enclomiphene citrate dosing considerations for children under 12, covering FDA labeling status, off-label use rationale, safety monitoring, and the absence of pediatric trial data.
Enclomiphene Citrate Pediatric (Under 12) Monitoring: Clinical Protocols and Safety
Evidence-based monitoring protocols for enclomiphene citrate use in pediatric patients under 12, including laboratory parameters, growth tracking, and safety considerations.
Enclomiphene Citrate Pediatric (Under 12) Safety
No clinical trials have tested enclomiphene citrate in children under 12. This article covers the absence of pediatric data, risks of SERM exposure in prepubertal children, and why pediatric endocrinologists use different approaches for childhood hormonal conditions.
Enclomiphene Citrate Pharmacogenomics and Genetic Variability
How CYP2D6, CYP3A4, ESR1, and other gene variants influence enclomiphene citrate response, dosing, and side-effect risk in men with secondary hypogonadism.
Enclomiphene Citrate Pharmacokinetics (ADME): Absorption, Distribution, Metabolism, and Excretion
An evidence-based deep dive into enclomiphene citrate pharmacokinetics covering absorption, protein binding, CYP-mediated metabolism, half-life, and clinical relevance for treating secondary hypogonadism.
Enclomiphene Citrate Real-World Evidence: What Registries and RWE Studies Actually Show
A clinician-level review of enclomiphene citrate real-world evidence, including registry data, RWE studies, mechanism of action, dosing, and how it compares to TRT for secondary hypogonadism.
Enclomiphene Citrate Regulatory Status: US, EU, Canada, and UK
Enclomiphene has no FDA approval as of 2026: the FDA issued three Complete Response Letters through 2015. US access remains via 503A and 503B compounding.
Enclomiphene Citrate Safety in Adolescents Ages 12 to 17
A clinical evidence review of enclomiphene citrate use in adolescents aged 12 to 17: what adult and pediatric-adjacent data show, what is unstudied, and the monitoring and consent standards this age group requires.
Enclomiphene Citrate Safety in Adults (30 to 49): What the Evidence Shows
A guide to enclomiphene citrate safety for adults aged 30 to 49, covering side effects, cardiovascular risks, liver monitoring, fertility preservation, and off-label prescribing considerations.
Enclomiphene Citrate Safety in Older Adults Ages 50 to 64
A clinical review of enclomiphene citrate safety for men ages 50 to 64, covering cardiovascular risk, polypharmacy interactions, dosing, monitoring protocols, and what current evidence says about long-term use in the andropause window.
Enclomiphene Citrate Safety in Young Adults (18 to 29): What the Evidence Shows
A guide to enclomiphene citrate safety for men aged 18, 29, covering testosterone restoration, fertility preservation, adverse effects, monitoring protocols, and current guideline positions.
Enclomiphene Citrate Safety Signals & FDA Actions: A Clinical Deep Dive
An evidence-based review of enclomiphene citrate's safety profile, FDA regulatory history, mechanism of action, and clinical trial data for secondary hypogonadism, written for clinicians and informed patients.
Showing the first 60 matches. Use search or filters to narrow the library.